Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on pain management. The Company's product portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone, and Nucynta ER and Nucynta IR (Nucynta Products), which are extended-release (ER) and immediate-release (IR) formulations of tapentadol. Xtampza ER is formulated using its abuse-deterrent technology platform, DETERx. Xtampza ER is for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults, and for which alternate treatment options are inadequate. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic, and for which alternative treatments are inadequate in adults.
Number of employees : 234 people.
|Pharmaceutical Products||296.70||100%||310.02||100%|| +4.49%|
|USD in Million
|United States||296.70||100%||310.02||100%|| +4.49%|
|USD in Million
|Vote ||Quantity||Free-Float||Company-owned shares||Total Float
|Janus Capital Management LLC ||4,098,911||
|Eventide Asset Management LLC ||2,629,593||
|Rubric Capital Management LP ||2,606,500||
|The Vanguard Group, Inc. ||2,242,669||
|Cadian Capital Management LP ||2,060,284||
|Camber Capital Management LP ||2,000,000||
|TPG Group Holdings (SBS) Advisors, Inc. ||1,436,960||
|HealthCor Management LP ||1,426,300||
|Renaissance Technologies LLC ||1,304,997||
|Franklin Advisers, Inc. ||1,240,994||
|Company contact information|
Collegium Pharmaceutical, Inc.
100 Technology Center Drive
Stoughton, MA 02072
Phone : +1.781.713.3699
Fax : +1.781.828.4697
Web : http://www.collegiumpharma.com
Sector Other Pharmaceuticals
Connections : Collegium Pharmaceutical, Inc.